首页> 中文期刊> 《结构化学》 >Synthesis, Configuration Judgment and Potentiation Activity of (2S,3S,E)-4-(3,4-Dihydroxybenzylidene)-3-(3,4-dihydroxyphenyl)-5-oxotetrahydrofuran-2-carboxylic Acid

Synthesis, Configuration Judgment and Potentiation Activity of (2S,3S,E)-4-(3,4-Dihydroxybenzylidene)-3-(3,4-dihydroxyphenyl)-5-oxotetrahydrofuran-2-carboxylic Acid

         

摘要

The title compound (2S,3S,E)-4-(3,4-dihydroxybenzylidene)-3-(3,4-dihydroxyphenyl)-5-oxotetrahydrofuran-2-carboxylic acid was synthesized and the 2D structure was characterized by 1H-NMR 13C-NMR and LCMS.The absolute configuration was determined by single-crystal X-ray diffraction of the key intermediate (2S,3S,E)-ethyl 4-(3,4-dimethoxybenzylidene)-3-(3,4-dimethoxyphenyl)-5-oxotetrahydrofuran-2-carboxylate.The crystal belongs to tetragonal system,space group P41 with a =13.0665(2),b =13.0665(2),c =13.4735(2) (A),V =2300.4(6) (A)3,Z =4,Dc =1.278 g/cm3,μ(CuKα) =0.801 mm-1,F(000) =936,S =1.050,R =0.0364 and wR (I > 2σ(I)) =0.1071.X-ray diffraction results showed that the molecular structure is stabilized totally by Van der Waals force.The antibacterial activity tests showed that the title compound possesses slight synergistic effect against MRSA and Acinetobacter baumanii.

著录项

  • 来源
    《结构化学》 |2017年第9期|1418-1424|共7页
  • 作者单位

    State Key Laboratory of New Drug and Pharmaceutical Process,Shanghai Institute of Pharmaceutical Industry,China State Institute of Pharmaceutical Industry,Shanghai 201203,China;

    Zhangjiang Branch Institute of China State Institute of Pharmaceutical Industry,Shanghai 201203,China;

    Shanghai Institute of Pharmaceutical Industry,Shanghai 201203,China;

    State Key Laboratory of New Drug and Pharmaceutical Process,Shanghai Institute of Pharmaceutical Industry,China State Institute of Pharmaceutical Industry,Shanghai 201203,China;

    State Key Laboratory of New Drug and Pharmaceutical Process,Shanghai Institute of Pharmaceutical Industry,China State Institute of Pharmaceutical Industry,Shanghai 201203,China;

    State Key Laboratory of New Drug and Pharmaceutical Process,Shanghai Institute of Pharmaceutical Industry,China State Institute of Pharmaceutical Industry,Shanghai 201203,China;

  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号